abs227.txt	a	compounding	feature	of	greater	than	50%	all	cancers	is	the	high	incidence	ofthe	cachexia	syndrome		complex	metabolic	disorder	characterized	by	extremeweight	loss	due	mainly	to	gross	depletion	skeletal	muscle	tissue	althoughstudies	into	cause	cancer	has	spanned	over	multiple	decades	little	known	about	effects	various	treatments	themselves	oncachexia	for	example	chemotherapy	agents	induce	side	such	as	nausea	andanorexia	but	these	symptoms	do	not	fully	account	changes	seen	withcancer	in	this	study	we	examine	chemotherapeuticcompounds	specifically	cisplatin	colon-26	adenocarcinoma	model	cancercachexia	find	that	although	able	reduce	tumor	burden	asexpected	wasting	mice	nevertheless	persists	strikingly	cisplatinalone	was	regulate	atrophy	which	independent	commonlyimplicated	ubiquitin	proteasome	system	finally	show	ableto	nf-Îºb	activity	both	mouse	muscles	and	myotube	cultures	suggestingthat	an	additional	effect	treatment	regulation	musclewasting	may	be	mediated	through	activation	signaling	pathway
